December 24, 2020 Comments Off on New patent for Vanda Pharms drug HETLIOZ Posted in: Patent Added Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Vanda Pharms drug HETLIOZ appeared first on DrugPatentW…
December 23, 2020 Comments Off on New patent for Neurocrine drug INGREZZA Posted in: Patent Added Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first on …